3Cui CY, Lu WL, Xiao L, et al. Sublingual delivery of insulin: effects of enhancers on the mucosal lipid fluidity and protein conformation, transport, and in vivo hypoglycemic activity [J]. Biol Pharm Bull, 2005, 28 (12) : 2279-2288.
4Xu HB, Huang KX, Zhu YS, et al. Hypoglycaemic effect of a novel insulin buccal formulation on rabbits [J]. Pharmacol Res, 2002, 46 (5) : 259-267.
5Smart JD. Lectin-mediated drug delivery in the oral cavity [J]. Adv Drug Del Rev, 2004, 56 (4) : 481-489.
6Veuillez F, Kalia YN, Jacques Y, et al. Factors and strategies for improving buccal absorption of peptides [J]. Eur J Pharm Biopharm, 2001, 51 (2) : 93-109.
7McInnes F, Clear N, James G, et al. Evaluation of the clearance of a sublingual buprenorphine spray in the beagle dog using gamma scintigraphy [J]. Pharm Res, 2008, 25 (4) : 869-874.
8Giannola LI, De Caro V, Giandalia G, et al. Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features[J]. Eur J Pharm Biopharm, 2007, 65 (2) : 238-246.
9Fadl A, Wang J, Zhang Z, et al. Effects of MDI spray angle on aerosol penetration efficiency through an oral airway cast [J]. JAerosol Sci, 2007, 38 (8) : 853-864.
10Dali MM, Moench PA, Mathias NR, et al. A rabbit model for sublingual drug delivery: comparison with human pharmacokinetic studies of propranolol, verapamil and captopril [J]. JPharm Sci, 2006, 95 (1) : 37-44.
